Oil prices turn lower as Bessent says U.S. may have Iran deal "today or tomorrow"

Investing.com -- Marvell Technology stock surged 10.0% in morning trading as the company opened the Flash Memory Summit 2026 in Santa Clara, California, unveiling a new portfolio of AI-focused memory and storage infrastructure products designed to serve the surging demands of agentic AI inference workloads. The centerpiece of the showcase is the Bravera SC6, a PCIe 6.0 SSD controller that doubles the throughput of its PCIe 5.0 predecessor, alongside rack-scale memory expansion and pod-level optical shared memory solutions aimed squarely at hyperscale and cloud deployments.

Analyst support remains a powerful tailwind. KeyBanc holds an Overweight rating with a $400 price target, raised after Asia supply-chain checks confirmed tight AI data center inventory and robust demand. Separately, Morgan Stanley flagged Google’s potential Frozen v2 custom AI chip as a 2027 design-win opportunity for Marvell, adding another forward-looking catalyst to the bull case. Reinforcing the long-term story, Marvell also announced a $250 million investment in India to expand its Bangalore and Hyderabad engineering hubs, double headcount, and deepen R&D in advanced AI-oriented semiconductors — effectively establishing India as its second-largest R&D center.

The broader market provided a constructive backdrop, with the NASDAQ advancing 1.19%, the S&P 500 gaining 0.56%, and the Dow Jones rising 1.20%, reflecting a risk-on tone that particularly benefits high-beta AI semiconductor names. Marvell’s peers in the custom silicon and data center networking space — including Broadcom and Astera Labs — also trade in a favorable environment as investor appetite for AI infrastructure exposure remains elevated heading into the second half of 2026.

Together, the live product catalyst at FMS 2026, a wall of bullish analyst price targets anchored by KeyBanc’s $400 objective, and the strategic India expansion announcement combined to reignite buying interest in a stock that had pulled back sharply from its 52-week high, with today’s move to $213.23 representing a meaningful recovery off the session’s $208.00 low.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Is MRVL undervalued—or a trap?

Gut instinct isn't enough. Our Fair Value calculator uses 17 proven valuation models to reveal what MRVL is really worth.
Get instant clarity on MRVL—plus thousands of other stocks—before the opportunity disappears.